Eloïse Laouenan Presents the Results of HEMOTHEPP-CHU Brest-GETBO Prospective Study
Eloïse Laouenan, PhD student in Life and Health Sciences, INSERM, shared on LinkedIn:
”Thanks to the CNGOF and the Pari(s) Santé Femmes congress for this opportunity to present the results of the epidemiology of VTE in the HEMOTHEPP/CHU Brest/GETBO prospective multicenter cohort study (20,238 unselected pregnant women included at delivery, followed 3 months).
Upcoming publication…
– High incidence of postpartum VTE
– Under-prescription of thromboprophylaxis
– Half of VTEs after 7 days postpartum
– High incidence in women at intermediate risk, with or without thromboprophylaxis
VTE risk assessment +++
Perspective: MUM-VTE CHU Brest/GETBO equals multicenter randomized controlled trial (F-CRIN INNOVTE) to evaluate the efficacy and safety of postpartum thromboprophylaxis in women at intermediate risk.
Thanks to all the patients and investigators.
Personal thanks to my team at Service de gynécologie obstétrique et médecine de la reproduction – CHU Brest !!!
Thanks for the photo and support!”
Stay updated with Hemostasis Today.
-
Sep 15, 2026, 14:19Mohammad Salar Amoli: The Coagulation Laboratory Approach to Hemophilia A
-
Sep 15, 2026, 14:09Lydia Pecker: A Call for Blood Donors for Sickle Cell Patients
-
Sep 15, 2026, 13:50Richard Godin: Challenges in Diagnosing Homozygous Familial Hypercholesterolemia
-
Sep 15, 2026, 13:42Sujan Sivasubramaniyam: Three Decades of Progress for Children with Haemophilia in Morocco
-
Sep 15, 2026, 13:31Mohammed Alkhani: Challenging the Conventional Approach to Paget-Schroetter Syndrome
-
Sep 15, 2026, 13:29Shadi Tabibian: Three Years of Progress Toward Life Beyond Hemophilia
-
Sep 15, 2026, 13:24Randall Curtis: Very Rewarding Week as a Co-Author, With a New Article in Production
-
Sep 15, 2026, 12:55Christopher Cannon: Calcium Scoring for Better Cardiovascular Risk Assessment
-
Sep 15, 2026, 12:55Lisa Krishtul: A Little Time Can Save a Life